NasdaqCM - Delayed Quote USD
Fennec Pharmaceuticals Inc. (FENC)
At close: October 18 at 4:00 PM EDT
After hours: October 18 at 6:51 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
23,040.0000
-17,143.0000
-18,058.0000
-14,222.0000
-15,595.0000
--
Financing Cash Flow
5,056.0000
6,638.0000
20,732.0000
4,978.0000
32,289.0000
--
End Cash Position
43,054.0000
13,269.0000
23,774.0000
21,100.0000
30,344.0000
--
Issuance of Capital Stock
--
--
--
--
31,967.0000
--
Issuance of Debt
--
4,997.0000
24,935.0000
5,000.0000
--
--
Repayment of Debt
--
--
-5,000.0000
--
--
--
Free Cash Flow
23,040.0000
-17,143.0000
-18,058.0000
-14,222.0000
-15,595.0000
--
12/31/2019 - 9/15/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EPRX Eupraxia Pharmaceuticals Inc.
2.5100
-1.57%
TCRX TScan Therapeutics, Inc.
5.37
+2.09%
SCPH scPharmaceuticals Inc.
4.5300
+3.19%
KALV KalVista Pharmaceuticals, Inc.
12.50
+3.39%
GBIO Generation Bio Co.
2.2600
-2.16%
ACTU Actuate Therapeutics, Inc. Common stock
7.26
-3.07%
OVID Ovid Therapeutics Inc.
1.2200
+4.27%
SLGL Sol-Gel Technologies Ltd.
0.6925
+1.99%
0Y2.BE INmune Bio Inc
4.7000
+1.73%
RPTX Repare Therapeutics Inc.
3.4300
+2.39%